Zhen Ding Financials
This page shows Zhen Ding (RBTK) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 12 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
The visible mechanic is liquidity strain: minimal cash and periodic financing support a business still carrying a fixed interest burden.
FY2025’s profit of$286.7K sits oddly beside interest expense of$497.9K , which means the year’s earnings did not come from a core operation that fully carries its financing burden. That reading is reinforced because operating cash flow was only$78.3K after a FY2024 net loss of-$1.1M , so the apparent turnaround looks more accounting-driven than cash-funded.
Short-term funding remains the binding constraint: FY2025 current assets were just
Book capital stayed underwater, with negative equity widening from
Financial Health Signals
Zhen Ding does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.
For every $1 of reported earnings, Zhen Ding generates $0.27 in operating cash flow ($78K OCF vs $287K net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.
Zhen Ding reported an operating loss of $96K against $498K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.
Key Financial Metrics
Earnings & Revenue
Zhen Ding reported $287K in net income in fiscal year 2025. This represents an increase of 125.9% from the prior year.
Zhen Ding earned $0.00 per diluted share (EPS) in fiscal year 2025. This represents an increase of 100.0% from the prior year.
Not reported for fiscal year 2025.
Not reported for fiscal year 2025.
Cash & Balance Sheet
Zhen Ding held $20K in cash as of fiscal year 2025; long-term debt is not reported for that period.
Not reported for fiscal year 2025.
Not reported for fiscal year 2025.
Margins & Returns
None of these metrics is reported for fiscal year 2025.
Capital Allocation
None of these metrics is reported for fiscal year 2025.
RBTK Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | TTM | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | $649K |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | $472K |
| Gross Profit | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | $177K |
| SG&A Expenses | N/A | $96K-84.1% | $605K-19.2% | $749K+970.0% | $70K+11.0% | $63K-8.3% | $69K+0.1% | $69K | N/A | N/A | N/A | N/A | $565K |
| Operating Income | N/A | -$96K+84.1% | -$605K+19.2% | -$749K-974.0% | -$70K-84.5% | -$38K+45.0% | -$69K-0.1% | -$69K | N/A | N/A | N/A | N/A | -$646K |
| Interest Expense | N/A | $498K-0.7% | $501K+0.6% | $498K-3.0% | $514K-3.4% | $532K-8.7% | $583K+6.4% | $548K | N/A | N/A | N/A | N/A | $546K |
| Income Tax | N/A | $0 | $0 | $0 | $0 | $0 | $0 | $0 | N/A | N/A | N/A | N/A | N/A |
| Net Income | N/A | $287K+125.9% | -$1.1M+11.3% | -$1.2M-113.8% | -$583K-39.0% | -$420K+35.6% | -$651K-5.7% | -$616K | N/A | N/A | N/A | N/A | -$1.2M |
| EPS (Diluted) | — | $0.00+100.0% | -$0.010.0% | -$0.01 | -$0.01 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Not reported in any period shown, so not listed: R&D Expenses.
TTM is the trailing twelve months, Q2 FY2025 through Q1 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.
RBTK Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | $7K-11.2% | $8K+10.9% | $7K+60.1% | $4K-99.8% | $2.4M |
| Current Assets | $20K+926.3% | $2K-68.6% | $6K-54.1% | $14K-54.0% | $30K+814.7% | $3K-64.3% | $9K+34.1% | $7K-11.2% | $8K+10.9% | $7K+60.1% | $4K-98.5% | $290K |
| Cash & Equivalents | $20K+926.3% | $2K-68.6% | $6K-54.1% | $14K-54.0% | $30K+814.7% | $3K-64.3% | $9K+54.0% | $6K-22.7% | $8K+10.9% | $7K+60.1% | $4K-47.3% | $8K |
| Accounts Receivable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | $100K |
| Total Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | $6.3M+3.2% | $6.1M+15.5% | $5.2M+3.4% | $5.1M-7.2% | $5.5M |
| Current Liabilities | $11.1M+1.6% | $10.9M+3.0% | $10.6M+2.7% | $10.3M-2.1% | $10.5M+8.5% | $9.7M+3.1% | $9.4M | N/A | N/A | N/A | N/A | N/A |
| Total Equity | -$7.7M-2.0% | -$7.6M-3.7% | -$7.3M-3.2% | -$7.1M+1.6% | -$7.2M-8.8% | -$6.6M+0.4% | -$6.7M-6.4% | -$6.3M-3.3% | -$6.1M-15.5% | -$5.2M-3.4% | -$5.1M-64.8% | -$3.1M |
| Retained Earnings | -$23.3M+0.7% | -$23.4M-4.3% | -$22.5M-5.2% | -$21.3M-2.1% | -$20.9M-2.0% | -$20.5M-2.5% | -$20.0M-2.4% | -$19.5M-2.7% | -$19.0M-2.6% | -$18.5M-2.7% | -$18.0M-14.4% | -$15.8M |
Not reported in any period shown, so not listed: Inventory, Goodwill, Long-Term Debt.
RBTK Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | TTM | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$318K | $78K+173.0% | -$107K-1258.2% | $9K+112.3% | -$75K+30.3% | -$108K+20.6% | -$136K-5.7% | -$129K | N/A | N/A | N/A | N/A | -$480K |
| Investing Cash Flow | N/A | N/A | N/A | N/A | $290-99.6% | $82K | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Financing Cash Flow | $102K | -$29K-127.7% | $105K+58.0% | $67K+26.7% | $53K-9.9% | $58K-7.2% | $63K+97.2% | $32K | N/A | N/A | N/A | N/A | $467K |
Not reported in any period shown, so not listed: Capital Expenditures, Free Cash Flow, Dividends Paid, Share Buybacks.
TTM is the trailing twelve months, Q2 FY2025 through Q1 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.
RBTK Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 27.3% |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -99.7% |
| Net Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -183.9% |
| Return on Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -49.8% |
| Current Ratio | 0.000.0x | 0.000.0x | 0.000.0x | 0.000.0x | 0.000.0x | 0.000.0x | 0.00 | N/A | N/A | N/A | N/A | N/A |
Not reported in any period shown, so not listed: Return on Equity, Debt-to-Equity, FCF Margin.
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Net Margin.
Note: Shareholder equity is negative (-$7.7M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Note: The current ratio is below 1.0 (0.00), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Where Zhen Ding Ranks
Frequently Asked Questions
Is Zhen Ding profitable?
Yes, Zhen Ding (RBTK) reported a net income of $287K in fiscal year 2025.
What is Zhen Ding's operating cash flow?
Zhen Ding (RBTK) generated $78K in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What is Zhen Ding's current ratio?
Zhen Ding (RBTK) had a current ratio of 0.00 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.
Why is Zhen Ding's debt-to-equity ratio negative or not reported?
Zhen Ding (RBTK) has negative shareholder equity of -$7.7M as of fiscal year 2025, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
Are Zhen Ding's earnings high quality?
Zhen Ding (RBTK) has an earnings quality ratio of 0.27x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Zhen Ding cover its interest payments?
Zhen Ding (RBTK) reported an operating loss of $96K against $498K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.